Healthcare Sector

Members of Parliament invested in the Healthcare Sector

157 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£130.19	201.09%	£210,760.86
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£130.19	182.22%	£197,556.90
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£14,492.00	20.53%	£84,367.93
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£14,492.00	252.09%	£246,462.59
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£15,316.00	295.10%	£276,569.07**
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£14,492.00	95.26%	£136,680.14
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£14,492.00	23.08%	£86,159.33
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£14,492.00	443.48%	£380,438.78
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£14,492.00	19.22%	£83,451.79
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£14,492.00	167.53%	£187,269.71
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£14,492.00	21.54%	£85,075.48
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£14,492.00	41.66%	£99,163.25
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£14,492.00	81.04%	£126,725.80
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£14,492.00	393.26%	£345,282.51
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£0.77	-76.74%	£16,283.99
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£55.63	48.78%	£104,148.17
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£56.69	6.10%	£74,271.01**
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£55.63	30.04%	£91,026.18
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£55.63	41.26%	£98,885.22
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£55.63	31.48%	£92,037.34
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£55.63	40.87%	£98,609.77
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£55.63	24.31%	£87,019.00
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£55.63	26.37%	£88,462.06
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£55.63	48.86%	£104,203.91
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£230.65	39.76%	£97,833.73
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£230.65	88.07%	£131,649.54
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£230.65	217.31%	£222,114.45
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£230.65	278.55%	£264,984.40
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£230.65	42.62%	£99,836.13
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£178.57	147.48%	£173,238.57
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£198.61	-20.20%	£55,860.39**
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£354.56	40.02%	£98,014.37
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£354.56	-27.65%	£50,645.23
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£354.56	-34.08%	£46,146.92
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£354.56	-31.58%	£47,895.02
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£354.56	-40.35%	£41,755.05
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,264.36	88.01%	£131,608.20
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£466.70	11.61%	£78,129.33
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£466.70	1.62%	£71,137.10
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£466.70	-20.04%	£55,974.57
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£466.70	0.79%	£70,553.30
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£466.70	-2.24%	£68,429.65
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£115.30	-81.18%	£13,174.99
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£115.30	-63.97%	£25,221.88
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£38.52	5.97%	£74,178.82
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£38.52	-62.12%	£26,515.88
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£38.52	-68.62%	£21,966.60
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£38.52	-71.39%	£20,023.76
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£116.06	-30.96%	£48,329.56
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£116.06	-28.72%	£49,896.82
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£147.48	66.87%	£116,809.23
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£147.48	123.29%	£156,303.59
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£147.48	172.90%	£191,031.96
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£165.00	-27.47%	£50,769.23
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£324.90	29.01%	£90,303.75
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£324.90	4.92%	£73,447.44
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£324.90	27.01%	£88,909.30
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£324.90	7.23%	£75,059.40
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£324.90	5.15%	£73,601.94
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£92.48	266.02%	£256,215.13
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£92.48	-15.02%	£59,489.07
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£92.48	181.09%	£196,765.95
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£15.50	-84.68%	£10,721.34
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£26.67	36.46%	£95,520.03
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£26.67	-8.11%	£64,325.36
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£31.92	41.21%	£98,845.20
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£31.92	52.14%	£106,499.44
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£311.20	257.33%	£250,132.07
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£329.65	374.86%	£332,404.21
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£329.65	19.87%	£83,910.91
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£46.10	-3.56%	£67,510.46
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£46.10	-16.11%	£58,726.11
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£9.96	-22.25%	£54,426.23
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£83.79	-16.85%	£58,204.83
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£78.86	-0.73%	£69,488.92
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£40.04	-57.97%	£29,422.63
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£190.67	-30.35%	£48,755.80
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£200.95	24.96%	£87,472.79
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£478.82	72.33%	£120,631.28
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£478.82	36.50%	£95,548.33
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£478.82	-13.15%	£60,797.03
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£474.03	1,428.14%	£1,069,700.19
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£25.25	0.96%	£70,671.16
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,530.00	-5.53%	£66,131.44
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£560.93	1,772.26%	£1,310,584.14
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£917.65	25.48%	£87,833.81
Apr '26	Lord Grabiner	Eli Lilly / NYQ:LLY	£955.19	£917.65	-3.93%	£67,248.93
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,402.50	-30.77%	£48,457.55
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£1.00	-97.69%	£1,617.00
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£785.60	41.04%	£98,728.90
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£7.04	402.86%	£352,000.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.23	16.15%	£81,302.08
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.76	-26.63%	£51,355.77
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£36.92	145.32%	£171,720.92
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14**
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.55	-95.42%	£3,208.33
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£15.09	42.09%	£99,463.28
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£9.50	-15.56%	£59,111.11
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£49.64	65.03%	£115,518.62
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£52.85	-52.80%	£33,037.15
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£351.60	4.61%	£73,228.21
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£4.53	-64.19%	£25,067.19
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£191.80	-7.57%	£64,703.62
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£191.80	-29.80%	£49,143.48
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.52	-97.98%	£1,413.46
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£76.50	-31.70%	£47,812.50
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£76.50	48.54%	£103,980.58
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£115.05	558.56%	£460,990.31
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.96	-86.80%	£9,240.00
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.80	-3.80%	£67,341.77

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.